Spectrum Collaborates with UCLA on Saliva-Based Liquid Biopsy Research for the Early Detection of Lung Cancer

Study to focus on using saliva in the analysis of cell-free circulating tumor DNA (ctDNA) to accurately and non-invasively detect non-small cell lung cancer (NSCLC).

PRESS RELEASE
Leslie Titus Bryant
January 27, 2021

Spectrum Solutions, LLC today announced its sponsored research collaboration with the UCLA School of Dentistry for a study on using saliva in early lung cancer detection and analysis. Spectrum has funded a study that aims to recruit 50 patients with lung cancer and seeks to validate saliva’s tumor-specific ctDNA detection sensitivity and positive agreement against tissue biopsy-based genotyping. Saliva will be collected, preserved, and transported for DNA testing using Spectrum’s Saliva Collection System. The company will further support the development of clinical methods and additional technical innovations.

The study is being led by professor of oral biology, Dr. David Wong, from the UCLA School of Dentistry, a research-intensive dental school and the lead U.S. research site for the study.

“Saliva-based liquid biopsy ctDNA detection can be used to not only provide an accurate cancer diagnosis, but additionally track the actionable mutations, monitor a response to treatments, and assess the emergence of drug resistance,” Dr. Wong said. “This study’s non-invasive use of saliva for the analysis of ctDNA will prove to overcome current limitations, provide procedures that improve detection sensitivity, and offer significant clinical impact on early detection, risk assessment, screening, diagnosis, and personalized/precision medicine.”

The research study will compare saliva and plasma samples from NSCLC patients to identify usctDNA molecules in saliva and use special extraction methods to improve overall sensitivity of current liquid biopsy procedures.

Press Release Header- UCLA - DR WONG Research Study Liquid Biopsy for Eary Detection of Lung Cancer

Photo Credit: Chris Flynn/ Dr. Wong UCLA School of Dentistry

“At Spectrum Solutions, we are proud to sponsor Dr. Wong and UCLA in this exciting research project to unlock and harness the potential of saliva as a primary diagnostic resource to combat and improve the lives and wellbeing of people around the world,” said Stephen Fanning, President, and CEO of Spectrum Solutions. “We look forward to working with the innovative researchers at UCLA and pledge our full support.”

ABOUT THE UCLA SCHOOL OF DENTISTRY

The UCLA School of Dentistry is dedicated to improving the oral health of the people of California, the nation, and the world. It has an international reputation for its teaching, research, patient care, and public service initiatives. The school provides education and training that develop leaders; conducts research programs that generate new knowledge; and delivers patient-centered oral health care to the community and state.

[Click to view this release online at Business Wire]

Spectrum Collaborates with UCLA on Saliva-Based Liquid Biopsy Research for the Early Detection of Lung Cancer

Study to focus on using saliva in the analysis of cell-free circulating tumor DNA (ctDNA) to accurately and non-invasively detect non-small cell lung cancer (NSCLC).

PRESS RELEASE
By: Leslie Titus Bryant
Director of Marketing & Brand
January 27, 2021

Spectrum Solutions, LLC today announced its sponsored research collaboration with the UCLA School of Dentistry for a study on using saliva in early lung cancer detection and analysis. Spectrum has funded a study that aims to recruit 50 patients with lung cancer and seeks to validate saliva’s tumor-specific ctDNA detection sensitivity and positive agreement against tissue biopsy-based genotyping. Saliva will be collected, preserved, and transported for DNA testing using Spectrum’s Saliva Collection System. The company will further support the development of clinical methods and additional technical innovations.

The study is being led by professor of oral biology, Dr. David Wong, from the UCLA School of Dentistry, a research-intensive dental school and the lead U.S. research site for the study.

“Saliva-based liquid biopsy ctDNA detection can be used to not only provide an accurate cancer diagnosis, but additionally track the actionable mutations, monitor a response to treatments, and assess the emergence of drug resistance,” Dr. Wong said. “This study’s non-invasive use of saliva for the analysis of ctDNA will prove to overcome current limitations, provide procedures that improve detection sensitivity, and offer significant clinical impact on early detection, risk assessment, screening, diagnosis, and personalized/precision medicine.”

The research study will compare saliva and plasma samples from NSCLC patients to identify usctDNA molecules in saliva and use special extraction methods to improve overall sensitivity of current liquid biopsy procedures.

Press Release Header- UCLA - DR WONG Research Study Liquid Biopsy for Eary Detection of Lung Cancer

Photo Credit: Chris Flynn/ Dr. Wong UCLA School of Dentistry

“At Spectrum Solutions, we are proud to sponsor Dr. Wong and UCLA in this exciting research project to unlock and harness the potential of saliva as a primary diagnostic resource to combat and improve the lives and wellbeing of people around the world,” said Stephen Fanning, President, and CEO of Spectrum Solutions. “We look forward to working with the innovative researchers at UCLA and pledge our full support.”

ABOUT THE UCLA SCHOOL OF DENTISTRY

The UCLA School of Dentistry is dedicated to improving the oral health of the people of California, the nation, and the world. It has an international reputation for its teaching, research, patient care, and public service initiatives. The school provides education and training that develop leaders; conducts research programs that generate new knowledge; and delivers patient-centered oral health care to the community and state.

[Click to view this release online at Business Wire]

Major League Baseball Logo

Bringing Baseball Back!

How you collect saliva makes a big difference

Increase workplace safety and build team confidence with simple and safe repeat testing programs supporting 100% accurate early detection and easy direct-to-user at-home options. Just ask Major League Baseball. See how our saliva collection system is credited for bringing baseball back” and making Salt Lake “the league’s most important city”.

™/© 2020 MLB

Major League Baseball Logo

Bringing Baseball Back!

How you collect saliva makes a big difference

Increase workplace safety and build team confidence with simple and safe repeat testing programs supporting 100% accurate early detection and easy direct-to-user at-home options. Just ask the Major League Baseball. See how our saliva collection system is credited for bringing baseball back” and making Salt Lake “the league’s most important city”.

™/© 2020 MLB

About Spectrum Solutions®

Headquartered in Salt Lake City, Utah, Spectrum Solutions is dedicated to empowering complete wellness and bridging the gap between science and innovative healthcare solutions. Our stand-alone and fully integrated test-to-treat solutions support molecular diagnostics and DTC testing applications, advancing product development and accelerating go-to-market applications. Our single-source, end-to-end capabilities include a CAP/CLIA accredited molecular diagnostic laboratory, onsite compounding pharmacy, medical and non-medical product development, manufacturing, and fulfillment.

#partoftheSolution

Leslie Titus Bryant Spectrum Solutions SpokesmanSpectrum Corporate Spokesman
Leslie Titus Bryant
Head of Marketing & Brand
admin@spectrumsolution.com

Tim Rush Public Relations, Springboard 5Media Contact
Tim Rush, Springboard5
801-208-1100
tim.rush@springboard5.com

About Spectrum Solutions®

Headquartered in Salt Lake City, Utah, Spectrum Solutions is dedicated to empowering complete wellness and bridging the gap between science and innovative healthcare solutions. Our stand-alone and fully integrated test-to-treat solutions support molecular diagnostics and DTC testing applications, advancing product development and accelerating go-to-market applications. Our single-source, end-to-end capabilities include a CAP/CLIA accredited molecular diagnostic laboratory, onsite compounding pharmacy, medical and non-medical product development, manufacturing, and fulfillment.

#partoftheSolution

Leslie Titus Bryant Spectrum Solutions SpokesmanSpectrum Corporate Spokesman
Leslie Titus Bryant
Head of Marketing & Brand
admin@spectrumsolution.com

Tim Rush Public Relations, Springboard 5Media Contact
Tim Rush, Springboard5
801-208-1100
tim.rush@springboard5.com

Noninvasive
Saliva Diagnostics

This changes everything!

Saliva analysis looks at the cellular level, the biologically active compounds, making it a true representative of what is clinically relevant. Engineered to lead the saliva collection industry, the BioMAX™ delivers the safest and most robust biosample for the earliest detection and diagnosis of disease and infection.

Since 2020 and the COVID-19 pandemic, Spectrum’s saliva collection system not only introduced, it continues to expand the molecular diagnostics industry and its understanding of the opportunities saliva offers patients, providers, and laboratories.

  • Pain-free, non-invasive, & safe
  • Saliva contains the entire library of proteins, hormones, antibodies, and other molecular compounds measured in routine blood tests
  • First EUA-authorized saliva collection device for COVID-19 testing
  • No temperature-controlled storage or transport of collected biosamples
  • A single saliva sample provides opportunity for multiple tests
  • Months and years of post-collection stability with no degradation in sample efficacy (depending on the analyte)
  • Maintain critical bio-sample consistency
  • Mitigates any risk of viral infection throughout the testing process
  • Delivers the highest levels of testing accuracy using qualified extraction chemistries

BIOMAX Blister Pack Saliva Collection Device

Noninvasive
Saliva Diagnostics

This changes everything!

Saliva analysis looks at the cellular level, the biologically active compounds, making it a true representative of what is clinically relevant. Engineered to lead the saliva collection industry, the BioMAX™ delivers the safest and most robust biosample for the earliest detection and diagnosis of disease and infection.

Since 2020 and the COVID-19 pandemic, Spectrum’s saliva collection system not only introduced, it continues to expand the molecular diagnostics industry and its understanding of the opportunities saliva offers patients, providers, and laboratories.

BIOMAX Blister Pack Saliva Collection Device

  • Pain-free, non-invasive, & safe
  • Saliva contains the entire library of proteins, hormones, antibodies, and other molecular compounds measured in routine blood tests
  • First EUA-authorized saliva collection device for COVID-19 testing
  • No temperature-controlled storage or transport of collected biosamples
  • A single saliva sample provides opportunity for multiple tests
  • Months and years of post-collection stability with no degradation in sample efficacy (depending on the analyte)
  • Maintain critical bio-sample consistency
  • Mitigates any risk of viral infection throughout the testing process
  • Delivers the highest levels of testing accuracy using qualified extraction chemistries

Are you a lab?

Let’s connect.

#partofthesolution

Outside-of-the-Box Thinking, Inside-of-the-Box Clinical Innovation

Anywhere from customized testing solutions to new medical science product innovations–we’re here to help.

Outside-of-the-Box Thinking, Inside-of-the-Box Innovation

Anywhere from customized testing solutions to new medical science product innovations–we’re here to help.

2022-05-31T18:57:08+00:00
Go to Top